-

Trinity Life Sciences Launches TGaS Advisors’ Government Pricing Services

Sixty-Three Percent of Emerging Life Sciences Companies Outsource Government Pricing Capabilities to a Third-Party Vendor Rather than Implement a System In-House

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the launch of Government Pricing (GP) services within TGaS Advisors. The new services help pre-commercial and emerging life sciences companies develop their GP policies and methodologies and provide support for ongoing GP calculations. Because drug pricing in the U.S. remains at the forefront of debates in Congress, rules and regulations continue to be dynamic, which poses compliance risks for drug manufacturers. GP calculations can also have a significant impact on a company’s bottom line if not carefully considered.

A new TGaS report entitled, Demystifying Government Pricing: A Lens into Industry Best Practices details how to ensure compliance, consistency and operational efficiency for Government Pricing teams. The report finds that 63 percent of emerging companies outsource GP capabilities, while only 25 percent regularly review and update GP policies and methodologies. The report is available exclusively to TGaS Pricing, Contracting and Analytics network members.

“Commercial contracting and pricing strategies are fundamental to an organization’s bottom line, and government pricing calculations should not be overlooked. Emerging companies have limited resources, and we are stepping up to help them fill this vital gap,” said Dmitry Kublanov, VP, Pricing, Contracting & Analytics, TGaS Advisors a division of Trinity Life Sciences.

Explore Trinity’s on-demand webinar for pre-commercial and emerging life science companies here, as TGaS’ Pricing and Contracting experts discuss common Government Pricing challenges that companies are facing. Topics include:

  • What are the “watch outs” that companies need to be thinking about?
  • How are companies resourcing to support Government Pricing calculations?
  • What systems are being used?
  • What validation methods are employed prior to submitting calculations?
  • What approaches are companies using to mitigate risk?

TGaS Advisors’ benchmarking and advisory services offer access to industry experts and the TGaS Client Network, fact-based answers grounded in unbiased comparative information and practical, actionable advice to achieve operational excellence. TGaS Advisors helps clients answer the question, “How do/should other life sciences companies do it?” regarding organization structure, resources, processes, people, technology and vendors.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom